Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lee Zou

Showing results (141-150 of 159) with videos related to

Pageof 16
Sort By:
Science Advances|August 14, 2020
Synthetic lethality by targeting the RUVBL1/2-TTT complex in mTORC1-hyperactive cancer cellsSeung Ho Shin, Ji Su Lee, Jia-Min Zhang, et al.
Neuro-Oncology|January 10, 2026
SMARCAL1 is a targetable synthetic lethal therapeutic vulnerability in ATRX-deficient gliomas that use Alternative Lengthening of TelomeresAlexandrea Brown, Laura M Strickland, Elise N Erman, et al.
The Oncologist|May 2, 2019
Analysis of DNA Damage Response Gene Alterations and Tumor Mutational Burden Across 17,486 Tubular Gastrointestinal Carcinomas: Implications for TherapyAparna R Parikh, Yuting He, Ted S Hong, et al.
Molecular Cancer Research : MCR|September 10, 2009
Prevalence and functional analysis of sequence variants in the ATR checkpoint mediator ClaspinJianmin Zhang, Young-Han Song, Brian W Brannigan, et al.
Nature Communications|August 28, 2024
EWS-WT1 fusion isoforms establish oncogenic programs and therapeutic vulnerabilities in desmoplastic small round cell tumorsGaylor Boulay, Liliane C Broye, Rui Dong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 15, 2019
The CHK1 Inhibitor Prexasertib Exhibits Monotherapy Activity in High-Grade Serous Ovarian Cancer Models and Sensitizes to PARP InhibitionKalindi Parmar, Bose S Kochupurakkal, Jean-Bernard Lazaro, et al.
Nature|May 4, 2022
CDC7-independent G1/S transition revealed by targeted protein degradationJan M Suski, Nalin Ratnayeke, Marcin Braun, et al.
Cell Reports|December 8, 2016
Genomic Instability Is Induced by Persistent Proliferation of Cells Undergoing Epithelial-to-Mesenchymal TransitionValentine Comaills, Lilian Kabeche, Robert Morris, et al.
Nature Communications|May 7, 2024
Author Correction: Meiotic protein SYCP2 confers resistance to DNA-damaging agents through R-loop-mediated DNA repairYumin Wang, Boya Gao, Luyuan Zhang, et al.
Nature Communications|February 21, 2024
Meiotic protein SYCP2 confers resistance to DNA-damaging agents through R-loop-mediated DNA repairYumin Wang, Boya Gao, Luyuan Zhang, et al.
Pageof 16

Showing results (141-150 of 159) with videos related to

Sort By:
Pageof 16
Science Advances|August 14, 2020
Synthetic lethality by targeting the RUVBL1/2-TTT complex in mTORC1-hyperactive cancer cellsSeung Ho Shin, Ji Su Lee, Jia-Min Zhang, et al.
Neuro-Oncology|January 10, 2026
SMARCAL1 is a targetable synthetic lethal therapeutic vulnerability in ATRX-deficient gliomas that use Alternative Lengthening of TelomeresAlexandrea Brown, Laura M Strickland, Elise N Erman, et al.
The Oncologist|May 2, 2019
Analysis of DNA Damage Response Gene Alterations and Tumor Mutational Burden Across 17,486 Tubular Gastrointestinal Carcinomas: Implications for TherapyAparna R Parikh, Yuting He, Ted S Hong, et al.
Molecular Cancer Research : MCR|September 10, 2009
Prevalence and functional analysis of sequence variants in the ATR checkpoint mediator ClaspinJianmin Zhang, Young-Han Song, Brian W Brannigan, et al.
Nature Communications|August 28, 2024
EWS-WT1 fusion isoforms establish oncogenic programs and therapeutic vulnerabilities in desmoplastic small round cell tumorsGaylor Boulay, Liliane C Broye, Rui Dong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 15, 2019
The CHK1 Inhibitor Prexasertib Exhibits Monotherapy Activity in High-Grade Serous Ovarian Cancer Models and Sensitizes to PARP InhibitionKalindi Parmar, Bose S Kochupurakkal, Jean-Bernard Lazaro, et al.
Nature|May 4, 2022
CDC7-independent G1/S transition revealed by targeted protein degradationJan M Suski, Nalin Ratnayeke, Marcin Braun, et al.
Cell Reports|December 8, 2016
Genomic Instability Is Induced by Persistent Proliferation of Cells Undergoing Epithelial-to-Mesenchymal TransitionValentine Comaills, Lilian Kabeche, Robert Morris, et al.
Nature Communications|May 7, 2024
Author Correction: Meiotic protein SYCP2 confers resistance to DNA-damaging agents through R-loop-mediated DNA repairYumin Wang, Boya Gao, Luyuan Zhang, et al.
Nature Communications|February 21, 2024
Meiotic protein SYCP2 confers resistance to DNA-damaging agents through R-loop-mediated DNA repairYumin Wang, Boya Gao, Luyuan Zhang, et al.
Pageof 16